Skip to main content

VIR Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Vir Biotechnology Inc. News

GlaxoSmithKline, Vir Say U.S. to Buy 600,000 More Covid Doses

The agreement includes the option for the U.S. to buy additional doses in the second quarter, the companies say.

Tech Stocks Surge, Dow Roars; Fauci Says Omicron Variant 'Almost Certainly' Less Severe Than Delta

Wall Street looks set to recoup all -- and more -- of last week's Omicron-linked declines as investors look past risks tied to the new variant, which may be milder and less virulent that first anticipated.

GlaxoSmithKline, Vir Biotechnology Say COVID Therapy Effective Against Omicron Variant

GlaxoSmithKline and its U.S. partner, Vir Biotechnology, said Tuesday that their COVID antibody is effective against all mutations of the new Omicron variant.

Intel, Samsung, Omicron, Tesla and Surging Stock Markets - 5 Things You Must Know

Stocks futures extend gains as Omicron risks fade, Glaxo and Vir Bio say COVID therapy effective against variant; Intel plans potential $50 billion Mobileye IPO; Samsung merges phone and electronics division in major restructuring and Elon Musk says Biden's EV incentives shouldn't pass congress.

Cramer's Mad Money Recap 12/2: Mastercard, Affirm, Boeing

Jim Cramer says market sentiment may be fickle, but it also can be a powerful driver of buying opportunities for investors who do their homework.

Breaking News

Elon Musk Says Only Two Things Could Make Him Leave Tesla

Tesla CEO Musk discusses succession plans and Twitter with shareholders.

Caesars Inches Closer to Huge Las Vegas Strip Move

The company has made clear what it plans on the Las Vegas Strip, but it has a fast-approaching deadline.

Elon Musk Has Bad News About Tesla's Cybertruck

Long-delayed futuristic looking electric vehicle will be in production by the middle of 2023